oral allosteric glucokinase activator

Ph. III candidate in T2DM

HbA1c reduction vs placebo

Nat. Med.

Hua Medicine, Shanghai, CN

Dorzagliatin Chemical Structure, oral allosteric glucokinase activator - Hua Medicine, Shanghai, CN

Context. Dorzagliatin (Hua Medicine) is an oral dual-acting full glucokinase (GK) activator being developed for type 2 diabetes. More than 50 years since the first report of the role…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: